Caitlin John’s Alpha Tau Medical DRTS Stock Holding History

Caitlin John’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.5K	Buy	1,765 +265	+18%	+$1.87K	0.01%	492
2025 Q4	$7.42K	Buy	+1,500	New	+$6.32K	﹤0.01%	583

Other funds holding DRTS

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Aquamarine Financial George Town $1.37B AUM

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return

DSC

Daytona Street Capital Saint Louis, Missouri $130M AUM

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

GIA

Gem Investment Advisors Teaneck, New Jersey $102M AUM

LCS

Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return

Caitlin John's DRTS Position: Q1 2026 in Review

Caitlin John increased its Alpha Tau Medical (DRTS) stake by 18% in Q1 2026, buying an estimated $1.87K and bringing the position to 1,765 shares worth $12.5K. The position accounts for 0.01% of the portfolio, ranked #492.

Caitlin John first reported a position in DRTS in Q4 2025 and has held it in 2 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

Caitlin John held 1,765 shares of Alpha Tau Medical worth $12.5K as of Q1 2026.
Caitlin John bought 265 Alpha Tau Medical shares in Q1 2026, an estimated $1.87K.
Alpha Tau Medical made up 0.01% of Caitlin John's portfolio in Q1 2026, its #492 holding.
Caitlin John first reported a position in Alpha Tau Medical in Q4 2025 and has held it in 2 quarters since.
53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.